Latest Asx Companies News

Page 5 of 6
Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.
Ada Torres
Ada Torres
30 June 2025
Hanwha Group claims US approval to fully own Austal, but independent checks suggest a narrower green light. Australian regulators still hold the final say on foreign ownership.
Victor Sage
Victor Sage
10 June 2025
Integral Diagnostics has announced the planned retirement of CEO Dr Ian Kadish at the end of FY26, with an international search underway for his successor. The transition comes as the company focuses on integrating its recent merger with Capitol Health.
Ada Torres
Ada Torres
6 June 2025
Develop Global has commenced concentrate production and cashflow at its Woodlawn copper/zinc mine, marking a significant milestone in its strategy to become a leading ASX copper and base metals company.
Maxwell Dee
Maxwell Dee
6 June 2025
Nyrada has secured ethics approval to amend its Phase I clinical trial protocol for Xolatryp, allowing testing of higher doses and extended infusion times. This strategic move aims to refine dosing ahead of Phase II trials, with final Phase I results expected by September 2025.
Ada Torres
Ada Torres
4 June 2025
Asara Resources assures investors its Kada Gold Project permits remain intact despite Guinea’s recent revocation of over 120 exploration permits. Drilling has already commenced, signaling continued progress.
Maxwell Dee
Maxwell Dee
28 May 2025
4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.
Ada Torres
Ada Torres
27 May 2025
Microba Life Sciences reveals preliminary data from over 4,600 MetaXplore GI Plus tests showing significant clinical findings in the majority of patients, with two-thirds reporting symptom improvements following test-guided care.
Ada Torres
Ada Torres
14 May 2025
GWA Group Limited has announced a fully franked ordinary dividend of AUD 0.075 per share for the half-year ending December 2024, signaling steady shareholder returns.
Victor Sage
Victor Sage
17 Feb 2025
Micro-X Ltd has secured a $6 million contract extension from the U.S. Department of Homeland Security to develop and test additional self-screening airport security checkpoints, marking a significant step forward in its innovative security technology program.
Sophie Babbage
Sophie Babbage
13 Feb 2025
Sandfire Resources Limited has announced the release date for its December 2024 half-year financial results, scheduled for February 20, 2025, accompanied by a live teleconference and webcast for investors.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Nyrada has secured ethics approval to begin its first-in-human Phase Ia trial of NYR-BI03, a promising neuro- and cardioprotective drug candidate. Recruitment starts soon, with dosing expected by March and results due in Q3 2025.
Ada Torres
Ada Torres
7 Feb 2025